Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Ceres Power is a technology-first fuel cell company that licenses its steel-cell technology and earns royalties as partners commercialize. As AI workloads drive demand for resilient, low-carbon power at scale, Ceres could see accelerating royalty cash flow. This trade targets a measured long with defined stop and upside based on commercialization c…
Quantum X Labs Inc. announced a significant advancement in nuclear quantum operations by developing an efficient approach to encode complex spatial geometries within a quantum transport framework. This breakthrough allows scalable quantum algorithms to better simulate particle transport in realistic nuclear environments, which traditionally face hi…
Cipher Digital has begun constructing lateral pipelines to supply natural gas to its industrial-scale data center sites, enabling on-site electricity generation capable of supporting up to 2.5 gigawatts. This development will enhance the company's leasable high-performance computing data center capacity and supports their plan to contribute to grid…
Victoria's Secret & Co. shares plunged in pre-market trading after the company reported second-quarter 2026 results that beat EPS estimates but were revealed to have been aided by a sizable one-time tariff refund. Investors reacted sharply to a weak operating income outlook for Q3 that implies significant margin compression despite revenue guidance…
Rising crude prices have improved the near-term outlook for major oil producers, but Chevron currently presents a clearer route for shareholders to benefit. West Texas Intermediate (WTI) trades at $92.33 and is up sharply year over year. On a valuation and income basis Chevron offers greater modeled upside and a higher yield, while Exxon remains th…
Profound Medical Corp., a commercial-stage medical device company specializing in interventional MRI procedures, announced its participation in the Lake Street Capital Markets BIG10 Conference. They focus on innovative therapies such as the TULSA-PRO system for prostate ablation and the Sonalleve system for non-surgical treatments of various condit…
Ocean Power Technologies (OPTT) announces the integration of Palantir Foundry, implemented by Palantir partner Foxtrot Professional Services, to enhance operational capabilities across manufacturing, supply chain, fleet operations, and customer support. This move supports OPT's strategic shift towards scalable, repeatable autonomous maritime system…
SRX Global Inc. provided a positive update on its portfolio company ARMR Sciences, a clinical-stage biodefense firm developing ARMR-100, an anti-fentanyl vaccine candidate. Phase 1/2 trials report strong immune response with favorable safety data, no severe adverse events, and dose escalation showing encouraging antibody responses. ARMR also receiv…
A Reuters poll of 32 foreign exchange analysts conducted Aug. 31-Sept. 2 found the Canadian dollar is forecast to slip slightly in the coming three months before strengthening over the next year if the trade conflict with the United States is settled. The Bank of Canada left its policy rate on hold at 2.25% while noting tariffs are unlikely to have…
Micron is positioned to capture an outsized share of the AI infrastructure spend as memory tightness moves from specialized HBM into mainstream DDR and NAND. Strong cash generation, sky-high ROE, and supportive technicals make a long entry at $955 with a $1,250 target and $820 stop over a 180-trading-day horizon.
Harmony Biosciences Holdings, Inc. announced it will present new data from ongoing clinical trials of its investigational drug EPX-100 (clemizole hydrochloride) for rare epileptic disorders at the 16th European Epilepsy Congress. EPX-100 is being studied for the treatment of Dravet syndrome and Lennox-Gastaut syndrome in the ARGUS and LIGHTHOUSE tr…
60 Degrees Pharmaceuticals, a U.S.-based biotech company focused on developing treatments for vector-borne diseases, announced its participation in the H.C. Wainwright 28th Annual Global Investment Conference scheduled for September 14-16, 2026. The company will provide an on-demand presentation starting September 11, with management available for …
Stellantis announced that its CEO, Antonio Filosa, will participate in a fireside chat at the 2026 Jefferies Global Industrials Conference in New York on September 10. The session will be webcasted live and later made available for replay on Stellantis' corporate website.
Jefferies has raised its long-term uranium price forecast from $70 to $95 per pound, arguing that higher production costs, capital intensity and execution risk mean current prices are insufficient to finance the new supply required. The brokerage expects primary production to peak at 243.4 million pounds in 2033, with China accounting for the bulk …
Skyworks Solutions, Inc. announced that its executives will participate in a fireside chat at the Goldman Sachs Communacopia and Technology Conference on September 10, 2026. The event will be webcast live and archived for replay on the company’s website. Skyworks is a leading provider of analog and mixed-signal semiconductors serving multiple secto…
TJX closed at $131.31 on Sep. 2 and was trading at $131.73 premarket on Sep. 3, 2026. With a calculated fair value of $129.70, the market-implied downside is roughly 1.2%. The decline to a 52-week low reflects a concrete operating issue - slowing Marmaxx comparable sales - while longer-term revenue and margin trends remain constructive. Technical i…
Micron's fundamentals and cash flow look like a monster hiding behind a modest P/E. With enterprise AI and HBM demand ramping, the stock appears mispriced at ~20x EPS. This trade idea lays out a defined long with entry, stop, and target, plus the catalysts and risks that could flip the thesis.
Satellogic has announced that all maritime intelligence derived from its upcoming Merlin satellite constellation will be exclusively distributed through SynMax's Theia platform. The Merlin constellation, launching in October 2026, offers daily global coverage at one-meter resolution to enhance vessel detection, dark-vessel identification, sanctions…
Kustom Entertainment, Inc. provided a detailed operational update on its pending acquisition of TFL, LLC (Tickets For Less), highlighting TFL's diversified and high-margin revenue streams exceeding $238 million in 2025. The integration is expected to unify ticketing infrastructure with Kustom's TicketSmarter platform, internalize ticketing margins …
Jyong Biotech Ltd., a Nasdaq-listed biotechnology company focused on plant-derived therapeutics for urinary system diseases, announced its participation in the StockFan Virtual Investor Non-Deal Roadshow scheduled for September 6-7, 2026. The event aims to engage investors, analysts, and media across multiple time zones with presentations in both M…
Tectonic Therapeutic, Inc., a clinical-stage biotechnology company specializing in therapeutic proteins and antibodies targeting GPCRs, announced that its CEO, Alise Reicin, will participate in a fireside chat at the Morgan Stanley 24th Annual Global Healthcare Conference. The event will provide insights into the company's proprietary GEODe platfor…
LB Pharmaceuticals has appointed Joseph Miller as Chief Financial Officer. Miller brings over 20 years of biopharmaceutical finance experience, including successful commercialization of a novel therapy. His expertise aims to support LB Pharmaceuticals as it approaches critical Phase 3 trial results for LB-102, a potential first benzamide antipsycho…
Krystal Biotech announced its participation in the 2026 Cantor Global Healthcare Conference where management will conduct a fireside chat and investor meetings. The company, a commercial-stage biotech specializing in genetic medicines, aims to showcase its innovative therapies such as VYJUVEK® and its growing pipeline to potential investors.
NANO Nuclear Energy Inc. announced significant progress in the development of the primary helium circulator for its KRONOS MMR Energy System, achieving an engineering milestone by advancing from preliminary engineering to detailed design in partnership with Howden, a Baker Hughes business. This collaboration enhances the foundation for the commerci…
Quince Therapeutics will participate in major healthcare investor conferences in September 2026 to discuss the development progress of its lead drug candidate, LAM-001, targeting serious pulmonary diseases. The company is advancing multiple Phase 2 clinical trials and aims to provide disease-modifying therapies for underserved conditions.
